← Back to news

Markets

Franklin Templeton Taps MoonPay to Bring Stablecoin Cash Into Tokenized Funds

Y

Victoria’s Secret Stock Surges 48% After Earnings. What’s Driving the Gains.

Y

The SpaceX IPO Is Whipping Space Stocks Into a Frenzy

Y

Signet Jewelers Q1 Earnings Call Highlights

Y

Absa gets approval to buy Standard Chartered Uganda assets

Y

The record-setting S&P 500 is putting up some impressive stats: By the numbers

Y

Credo Just Told The Market Something Bigger Than Earnings

S

Salesforce (CRM) Shows Narrative Divergence Amid Anthropic’s Developments

Y

Tech Tuesday: Coppel Teams with First Insight

Y

Netflix Nearing 52-Week Low: Buy, Sell or Hold?

Y

KB (KB) Q1 2026 Earnings Call Transcript

Y

Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?

Y

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating

Y

Evaluating Zoom’s (ZM) Event-Driven Trade

Y

Is Fold Holdings, Inc. (FLD) Under Pressure After Revenue Drops 21% in Q1 2026?

Y

Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?

Y

TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss

Y

Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results

Y

Is Expensify, Inc. (EXFY) Strengthening Its Expense Ecosystem Through New VAT Reclaim Partnership?

Y

Covenant (CVLG) Q1 2026 Earnings Transcript

Y

GoPro, Inc. (GPRO) Stock Focus Shifts to Diversification Beyond Action Cameras

Y

Target vs Walmart: Both Fighting For The Same Customer, Only One Wins

Y

Business Owners: The One Tax Move Financial Advisors Say You Can’t Skip Before Year-End

Y

Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity

Y

Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?

Y

Is ESS Tech, Inc. (GWH) Still a Buy After Softer Q1 Results and Lower Price Target?

Y

MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress

Y

Cleveland Fed president warns rate hikes could be on the table 'if recent trends continue' with inflation

Y

Core Scientific (CORZ): A Shovel-Ready Leader in the AI Tech Landscape

Y

Hallador to buy Siemens turbines from EWC for $350m

Y

FIBK Q4 2025 Earnings Transcript

Y

FIBK Q1 2026 Earnings Transcript

Y

Income Safe-Haven Under $40: Why This Packaging Giant’s 5.8% Yield Is Mispriced

Y

Elizabeth Warren Branded Kevin Warsh Trump’s ‘Sock Puppet.’ His First Fed Meeting May Prove Her Wrong

Y

Belden (BDC) is Set to Benefit from Secular Tailwinds

Y

Should You Consider Selling Crocs (CROX)?

Y

South Africa’s Tiger to sell chocolate brand Beacon

Y

ChatGPT Says You Should Buy Amphenol (APH) – ‘A Cleaner Way to Ride AI CapEx’

Y

Is Mondelez International Stock Underperforming the Dow?

Y

Cango (CANG) Q1 2026 Earnings Transcript

Y

What Makes Barrett Business Services (BBSI) a Good Investment?

Y

As Software M&A Heats Up, These 3 Acquisition Targets Are in the Spotlight

Y

Is Airbnb Stock Underperforming the S&P 500?

Y

Salesforce vs. ServiceNow: 1 AI Giant Is Leaving the Other Behind

Y

Fortune Brands Innovations (FBIN) Gains from Favorable Demand Trends

Y

Celestica Ready To Explode Higher - 2 Reasons

S

Nvidia CEO Endorses Marvell As Next Trillion-Dollar Giant. Stock Jumps 29%.

Y

SpaceX negotiating underwriting fees under 0.75% for IPO, Bloomberg News reports

Y

MoneyGram Launches New Stablecoin

Y

How Is Starbucks’ Stock Performance Compared to Other Consumer Discretionary Stocks?

Y